Clinical Trial Update: Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and Placebo [Phase 2]

View source ↗

Summary

Phase 2 study comparing two fixed-dose combinations of aclidinium bromide with formoterol fumarate against aclidinium bromide, formoterol fumarate, and placebo …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Aclidinium bromide/formoterol fumarate fixed-dose combination (Dose 1) (aclidinium bromide/formoterol fumarate)
• Aclidinium bromide/formoterol fumarate fixed-dose combination (Dose 2) (aclidinium bromide/formoterol fumarate)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED | Results posted: 2016-11-09